Advanced glycation end products and diabetic nephropathy: a comparative study using diabetic and normal rats with methylglyoxal-induced glycation

Angiopoietin-2 Is Associated with Albuminuria and Microinflammation in Chronic Kidney Disease

(2013) Fan-Chi Chang et al.   PLoS One

Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis

(2013) Rukshana C. Shroff et al.   PLoS One

The Renal Endothelium in Diabetic Nephropathy

(2013) Theodoros Eleftheriadis et al.   RENAL FAILURE

Methylglyoxal promotes oxidative stress and endothelial dysfunction

(2012) Cristina M. Sena et al.   PHARMACOLOGICAL RESEARCH

The Endothelium in Diabetic Nephropathy

(2012) Andrew Advani et al.   SEMINARS IN NEPHROLOGY

Methylglyoxal causes structural and functional alterations in adipose tissue independently of obesity

(2012) P. Matafome et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Metformin restores endothelial function in aorta of diabetic rats

(2011) Cristina M Sena et al.   BRITISH JOURNAL OF PHARMACOLOGY

Targeted reduction of advanced glycation improves renal function in obesity

(2011) Brooke E. Harcourt et al.   KIDNEY INTERNATIONAL

Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse

(2010) Nina Reiniger et al.   DIABETES

Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction

(2010) C. F. Bento et al.   EXPERIMENTAL PHYSIOLOGY

The Importance of Cellular VEGF Bioactivity in the Development of Glomerular Disease

(2009) Rebecca R. Foster   NEPHRON EXPERIMENTAL NEPHROLOGY

What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?

(2008) S. C. Satchell et al.   DIABETOLOGIA